Translation of "Upper airway" in German

When set up, it removals the jaw a slight to open the upper airway.

Help in releasing the upper airway.

Pregabalin should be discontinued immediately if symptoms of angioedema, such as facial, perioral, or upper airway swelling occur.

When set up, it removals the jaw a minor to open up the upper airway.

Snoring is caused by a partially closed upper airway (the nose and throat).

Today's devices all require a sufficiently large, free upper airway in the patient.

Once installed, it moves the jaw a slight to open the upper airway.

Once installed, it removals the jaw a small to open the upper airway.

Snoring occurs when the upper airway narrows or even closes temporarily.

In most cases, snoring is caused by a narrowing of the upper airway between the throat and nasal cavity during sleep.

Once set up, it removals the jaw a small to open up the upper airway.

The stop snoring device opens the upper airway and immediately stops the cause of snoring.

As soon as set up, it removals the jaw a mild to open the upper airway.

As soon as installed, it moves the jaw a slight to open the upper airway.

You can Google it, but it's an infection, not of the throat, but of the upper airway, and it can actually cause the airway to close.

After improvement of the congestive condition of the mucosae of the upper airway, treatment may be maintained with desloratadine alone, if necessary.

Additionally, a few patients who had a prior history of severe MPS I- related upper airway and pulmonary involvement, experienced severe reactions including bronchospasm, respiratory arrest, and facial oedema (see section 4.4).

However, a few patients who had a prior history of severe MPS I related upper airway and pulmonary involvement, experienced severe reactions including bronchospasm, respiratory arrest, and swelling of the face.

There have been reports of sleep apnoea and sudden death after initiating therapy with growth hormone in paediatric patients with Prader-Willi syndrome who had one or more of the following risk factors: severe obesity, history of upper airway obstruction or sleep apnoea, or unidentified respiratory infection.

If during treatment with somatropin patients show signs of upper airway obstruction (including onset of or increased snoring), treatment should be interrupted, and a new ENT assessment performed.

In case symptoms such as angioedema (tongue or throat swelling), upper airway obstruction or hypotension occur during or immediately after infusion, anaphylaxis or an anaphylactoid reaction should be suspected.

There have been reports of sleep apnoea and sudden death after initiating growth hormone therapy in patients with Prader-Willi syndrome, who had one or more of the following risk factors: severe obesity, history of upper airway obstruction or sleep apnoea, or unidentified respiratory infection.

A few patients who had a prior history of severe MPS I related upper airway and pulmonary involvement, experienced severe reactions including bronchospasm (airway constriction), respiratory arrest, and swelling of the face.

These reactions may be particularly severe if you have a pre-existing MPS I-related upper airway obstruction.

One clinical study focussed mainly on assessing the effect of Aldurazyme on the systemic manifestations of MPS I such as poor endurance, restrictive lung disease, upper airway obstruction, reduced joint range of motion, hepatomegaly and visual impairment.